Lieven ANNEMANS, Department of Public Health and Primary Care, UGent

Tamas BERECZKY, EUPATI

Giovanni BRIGANTI, Lecturer in Medical Technology, ULB

Yves COPPIETERS, École de Santé publique, ULB

Anne DANNIAU, UCB

Jo DE COCK, NIZIV

Jean-Pol DETIFFE, OncoDNA, Gosselies

Mathias DEWATRIPONT, I3h Institute & Solvay Brussels School, ULB

Lode DEWULF, Servier

Anne-Laure DRENO, AstraZeneca, Brussels

Hans-Georg EICHLER, European Medicines Agency

Bruno FLAMION, Namur Research Institute for Life Sciences, UNamur

Marius GILBERT, Spatial Epidemiology lab, ULB

Michel GOLDMAN, I3h Institute, ULB

Emmanuel HANON, GSK,

Mike HARDMAN, Faculty of Pharmaceutical Medicine, UK

Bill HAUSDORFF, PATH

Hetty HELSMOORTEL, CRIG

Isabelle HUYS, Pharmaceutical and Pharmacological Sciences, KULeuven

Yves JONGEN, IBA, Louvain-la-Neuve

HeeJung JUNG, Imperial College, London

Dipak KALRA, University College of London

Michel KAZATCHKINE, UN Special Envoy for HIV/AIDS

Ingrid KLINGMANN, Pharmatrain Federation

Anatole KRATTIGER, Prisma Innovations LLC, Geneva

Heidi LARSON, London School of Hygiene & Tropical Medicine

Agnès MATHIEU-MENDES, European Commission

Philippe MONTEYNE, Fund+

Mattias NEYT, Belgian Health Care Knowledge Centre, KCE

Magda PAPADAKI, MSD

Peter PIOT, London School of Hygiene & Tropical Medicine

Hilde STEVENS, I3h Institute, ULB

Ellen t’HOEN, Medicines Law & Policy

Dimitrios TZALIS, Taros GmbH, Dortmund

Sophie VANDEBROEK, IDEXX Laboratories

Roos VANDENBROUCKE, VIB-UGent Center for Inflammation Research

Bruno VAN POTTELSBERGHE, Solvay Brussels School, ULB

Richard WILDER, Coalition for Epidemic Preparedness Innovation

*Tentative schedule. Speakers tbc